Evaluation of CPD MNV as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)
| Status: | Recruiting |
|---|---|
| Conditions: | Hospital, Hospital |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - 90 |
| Updated: | 4/2/2016 |
| Start Date: | August 2014 |
| End Date: | August 2019 |
| Contact: | Elliott Crouser, MD |
| Phone: | 614-293-4978 |
Evaluation of CPD (Cell Population Data) MNV (Mean Neutrophil Volume) as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)
The investigators hypothesize that CPD parameters will provide improved prediction of sepsis
compared to currently employed laboratory parameters. These studies hold the potential to
shape practitioner guidelines and improve the timeliness and accuracy with which patients
with sepsis are treated today.
compared to currently employed laboratory parameters. These studies hold the potential to
shape practitioner guidelines and improve the timeliness and accuracy with which patients
with sepsis are treated today.
Inclusion Criteria:
- Adult (≥18 to 90 years)
- Patients presenting to the Emergency Department
- CBC (Complete Blood Count) with differential testing performed and CPD data retrieved
Exclusion Criteria:
- Previously enrolled in this study
We found this trial at
1
site
Click here to add this to my saved trials
